{"id":206715,"name":"CENTRIENT PHARMACEUTICALS LLC","slug":"centrient-pharmaceuticals-llc","state":"CA","country":"United States of America","description":"Pharmaceutical Manufacturing","totalSpending":2000000,"filings":25,"yearlySpending":[{"year":2020,"income":250000},{"year":2021,"income":560000},{"year":2022,"income":700000},{"year":2023,"income":160000},{"year":2024,"income":100000},{"year":2025,"income":230000}],"issues":[{"code":"MAN","display":"Manufacturing"},{"code":"PHA","display":"Pharmacy"},{"code":"HCR","display":"Health Issues"},{"code":"BUD","display":"Budget/Appropriations"},{"code":"DEF","display":"Defense"},{"code":"TRD","display":"Trade (domestic/foreign)"}],"firms":["AKIN GUMP STRAUSS HAUER & FELD"],"lobbyists":["GEOFF VERHOFF","HEIDE BAJNRAUH","DANIEL GRAVER","CHARLIE JOHNSON","MATTHEW HITTLE","ANNA ABRAM","SEAN FEELY","LOUIS AGNELLO","STEPHEN KHO","MARIO RAMIREZ","ED PAGANO","CASEY HIGGINS","SAM OLSWANGER"],"govEntities":["Health & Human Services, Dept of (HHS)","Overseas Private Investment Corp (OPIC)","HOUSE OF REPRESENTATIVES","Natl Economic Council (NEC)","Natl Security Agency (NSA)","Natl Security Council (NSC)","SENATE","Commerce, Dept of (DOC)","Food & Drug Administration (FDA)","State, Dept of (DOS)","U.S. Trade Representative (USTR)","White House Office","Office of Science & Technology Policy (OSTP)","Office of Management & Budget (OMB)"],"sampleDescriptions":["Reshoring production of essential medicines.","Reshoring production of essential medicines.","Reshoring production of essential medicines.","Reshoring production of essential medicines.","Reshoring production of essential medicines."]}